Efficacy of melatonin in non-intensive care unit patients with COVID-19 pneumonia and sleep dysregulation | ||
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | No especifíca | |
| dc.conicet.organizacion | No especifíca | |
| dc.conicet.organizacion | No especifíca | |
| dc.conicet.organizacion | Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas | |
| dc.conicet.organizacion | Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas | |
| dc.contributor.author | Brusco, Luis Ignacio | |
| dc.contributor.author | Cruz, Pablo | |
| dc.contributor.author | Cangas, Alicia | |
| dc.contributor.author | González Rojas, Carmen | |
| dc.contributor.author | Vigo, Daniel Eduardo | |
| dc.contributor.author | Cardinali, Daniel Pedro | |
| dc.date.issued | 2021-01 | |
| dc.description.abstract | The association of sleep disruption with a higher vulnerability to COVID-19 infection is asubject of major clinical importance. In patients with pneumonia associated with COVID-19admitted to non-intensive care unit (NICU) several factors, like the disrupting influence ofrespiratory distress, medication, greater stress due to social isolation, and lack of appropriateexposure to environmental light can be instrumental to disrupt sleep / wake cycle. Thetherapeutic potential of melatonin to counteract the consequences of COVID-19 infection hasbeen advocated. Because of its wide-ranging effects as an antioxidant, anti-inflammatory, andimmunomodulatory compound, melatonin could be unique in impairing the consequences ofSARS-CoV-2 infection. Melatonin is also an effective chronobiotic agent to reverse the circadiandisruption of social isolation and to control delirium in severely affected patients. Properlyadministered, melatonin may restore the optimal circadian pattern of the sleep-wake cycle andimprove clinical condition in pneumonia associated with COVID-19 patients. The present reviewarticle discusses the importance of maintaining normal sleep and circadian rhythmicity in NICUpatients and provides preliminary data suggesting the efficacy of melatonin (9 mg/day) to reducelength of stay of pneumonia patients associated with COVID-19 in NICU. | es |
| dc.description.fil | Fil: Brusco, Luis Ignacio. Universidad de Buenos Aires. Facultad de Medicina; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Cruz, Pablo. No especifíca; | |
| dc.description.fil | Fil: Cangas, Alicia. No especifíca; | |
| dc.description.fil | Fil: González Rojas, Carmen. No especifíca; | |
| dc.description.fil | Fil: Vigo, Daniel Eduardo. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina | |
| dc.description.fil | Fil: Cardinali, Daniel Pedro. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Brusco, Luis Ignacio; Cruz, Pablo; Cangas, Alicia; González Rojas, Carmen; Vigo, Daniel Eduardo; et al.; Efficacy of melatonin in non-intensive care unit patients with COVID-19 pneumonia and sleep dysregulation; Open Journal Systems; Melatonin Research; 4; 1; 1-2021; 173-188 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 2641-0281 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/134834 | |
| dc.journal.number | 1 | es |
| dc.journal.pagination | 173-188 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Melatonin Research | es |
| dc.journal.volume | 4 | es |
| dc.language.iso | eng | es |
| dc.publisher | Open Journal Systems | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.32794/mr11250089 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by/2.5/ar/ | * |
| dc.subject | CHRONOTHERAPY | es |
| dc.subject | COVID-19 PANDEMIC | es |
| dc.subject | MELATONIN | es |
| dc.subject | PNEUMONIA | es |
| dc.subject | RESPIRATORY DISTRESS | es |
| dc.subject | SLEEP | es |
| dc.subject | COVID-19 | es |
| dc.subject.classification | Neurociencias | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Efficacy of melatonin in non-intensive care unit patients with COVID-19 pneumonia and sleep dysregulation | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.12aad149-bb35-497c-9006-d46b17f3dbc3_A.pdf
- Tamaño:
- 357.83 KB
- Formato:
- Adobe Portable Document Format